Concourse Financial Group Securities, Inc. Eton Pharmaceuticals, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding ETON
# of Institutions
64Shares Held
10.3MCall Options Held
261KPut Options Held
500-
Opaleye Management Inc. Boston, MA2.78MShares$46.1 Million3.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$17.6 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT999KShares$16.5 Million0.36% of portfolio
-
Westside Investment Management, Inc.575KShares$9.53 Million1.61% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA566KShares$9.38 Million0.15% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $419M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...